These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7442702)

  • 21. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9.
    Prival MJ; Mitchell VD
    Mutat Res; 1982 Apr; 97(2):103-16. PubMed ID: 7043259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An improvement of the Ames test using a modified human liver S9 preparation.
    Hakura A; Suzuki S; Sawada S; Motooka S; Satoh T
    J Pharmacol Toxicol Methods; 2001; 46(3):169-72. PubMed ID: 12183193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of metabolic activation on the cytotoxicity and mutagenicity of 1,2-dibromoethane in the CHO/HGPRT system.
    Brimer PA; Tan EL; Hsie AW
    Mutat Res; 1982 Aug; 95(2-3):377-88. PubMed ID: 6750385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
    Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y
    Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic activation of 2- and 3-nitrodibenzopyranone isomers and related compounds by rat liver S9 and the effect of S9 on the mutational specificity of nitrodibenzopyranones.
    Watanabe T; Kaji H; Takashima M; Kasai T; Lewtas J; Hirayama T
    Mutat Res; 1997 Jan; 388(1):67-78. PubMed ID: 9025793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the mutagenicity of three dinitropyrene isomers in vitro by rat-liver S9, cytosolic, and microsomal fractions following chronic ethanol ingestion.
    Winston GW; Traynor CA; Shane BS; Hajos AK
    Mutat Res; 1992 Jun; 279(4):289-98. PubMed ID: 1377785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal levels of S9 fraction in the Ames and fluctuation tests: apparent importance of diffusion of metabolites from top agar.
    Forster R; Green MH; Priestley A
    Carcinogenesis; 1980 Apr; 1(4):337-46. PubMed ID: 7023716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deactivation of furyl furamide (AF-2) by rat-liver microsomes and its implication in short-term tests for mutagenicity/carcinogenicity.
    Murthy MS; Najaria KB
    Mutat Res; 1980 Feb; 77(2):127-34. PubMed ID: 6990237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing.
    Burke DA; Wedd DJ; Herriott D; Bayliss MK; Spalding DJ; Wilcox P
    Mutagenesis; 1994 Jan; 9(1):23-9. PubMed ID: 8208127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of a furocoumarin epoxide, heraclenin, in Chlamydomonas reinhardii.
    Schimmer O; Abel G
    Mutat Res; 1986; 169(1-2):47-50. PubMed ID: 3945236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of 8-methoxypsoralen and ultraviolet light on sister chromatid exchange.
    Wulf HC
    Arch Dermatol Res; 1978 Sep; 263(1):37-46. PubMed ID: 718262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
    Oesch F; Bücker M; Glatt HR
    Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
    Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
    J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity in V79 cells does not correlate with carcinogenity in small rodents for 12 aromatic amines.
    Fassina G; Abbondandolo A; Mariani L; Taningher M; Parodi S
    J Toxicol Environ Health; 1990; 29(1):109-30. PubMed ID: 2299684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the relationship of metabolic activation system concentrations and chemical dose concentrations for the Salmonella spiral and plate assays.
    Claxton LD; Houk VS; Allison JC; Creason J
    Mutat Res; 1991 Oct; 253(2):127-36. PubMed ID: 1922139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.